Clinical Trial Update: Phase Ⅰ/Ⅱ Study of SHR2554 in Combination With SHR1701 in Patients With Advanced Solid Tumors and B-cell Lymphomas [Phase 1, Phase 2]

View source ↗

Summary

Phase Ⅰ/Ⅱ study evaluating SHR2554 in combination with SHR1701 in advanced solid tumors and B-cell lymphomas is underway, with no current status available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Solid Tumor

Drugs mentioned

• SHR1701
• SHR2554

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Solid Tumor, Lymphoma | Phase 1, Phase 2 | Status: UNKNOWN